• Kiora Pharmaceuticals appointed Keith J. Lane as executive vice president of global clinical development and regulatory affairs.
• Lane previously served as chief scientific officer at Ora, overseeing clinical operations and regulatory strategy for more than 60 ophthalmic trials.
• His background includes more than 20 years in ophthalmic drug development across Phase 1 to Phase 4 programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiora Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609080700NEWSFILECNPR____20260908_313082_1) on September 08, 2026, and is solely responsible for the information contained therein.